Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 13th of July 2026

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. 

From the week of July 13th, we are planning to work on 14 projects, including: 

Reimbursement 

1. Initiating reimbursement analysis for minimally invasive technologies in oncology area in England, Germany, and the Netherlands 
2. Initiating reimbursement analysis for molecular diagnostic technologies in 12 European countries 
3. Working on reimbursement analysis for implanted medical devices in the surgical area in Belgium, Germany, and Switzerland 
4. Working on reimbursement analysis for surgical treatment in the ophthalmology area in England, France, Italy, the Netherlands, Spain, Sweden, and Switzerland 
5. Working on reimbursement analysis for an in-vitro diagnostic test in infectious disease areas in England, France, Germany, and Spain 
6. Working on analysis or coverage and reimbursement framework for point-of-care tests in England, Germany, Italy, the Netherlands, and Spain 
7. Working on market size analysis for diagnostic technology in the neurology area in Germany 
8. Working on reimbursement and HTA analysis for minimally invasive surgery in the cardiovascular area in Germany and Spain 

HEOR 

1. Delivering validation of a health economic model in the cardiology area 
2. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain  
3. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test 
4. Working on the development of a health economic model for technology in the cardiovascular area in England 
5. Working on the development of a value dossier for a neuromodulation therapy in the neurology area 
6. Working on the development of a value dossier for a personalized blood test in the oncology area 

Let us know if you need any market access or HEOR support for your medical technology in Europe